Elderly patients with chronic hepatitis C receiving combined treatment with IFN and RBV have a higher likelihood of side effects and a significantly lower rate of virological response at the end of the treatment and 6 months afterward than younger adults.

Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?

FLOREANI, ANNAROSA;CARDERI, ISABELLA;BALDO, VINCENZO
2006

Abstract

Elderly patients with chronic hepatitis C receiving combined treatment with IFN and RBV have a higher likelihood of side effects and a significantly lower rate of virological response at the end of the treatment and 6 months afterward than younger adults.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11577/2432332
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 27
social impact